Efficacy of nivolumab/ipilimumab as first-line treatment of pleural mesothelioma in the German real-world setting

被引：0
|
作者：
Shah, Rajiv
Reck, Martin
Grohe, Christian
Christoph, Daniel Christian
Buchmeier, Eva Lotte
Saalfeld, Felix Carl
Frost, Nikolaj
Kopp, Hans-Georg
Faehling, Martin
Griesinger, Frank
Roeper, Julia
Hoffknecht, Petra
Kuon, Jonas
Luan, Jingting
Chesi, Paolo
Christopoulos, Petros
Thomas, Michael
机构：
[1] Heidelberg Univ Hosp, Dept Thorac Oncol, Heidelberg, Germany
[2] NCT Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany
[3] TLRC H, Heidelberg, Germany
[4] German Ctr Lung Res, Heidelberg, Germany
[5] German Ctr Lung Res DZL, Lungen Clin Grosshansdorf, Airway Res Ctr North ARCN, Grosshansdorf, Germany
[6] Evangel Lungenklin Berlin, Klin Pneumol, Berlin, Germany
[7] Evang Kliniken Essen Mitte, Dept Med Oncol, Essen, Germany
[8] Klinikum Stadt Koln gGmbH, Cologne, Germany
[9] Univ Hosp Dresden, Clin Internal Med 1, Dresden, Germany
[10] Charite Univ Med Berlin, Berlin, Germany
[11] Free Univ Berlin, Berlin, Germany
[12] Humboldt Univ, Berlin, Germany
[13] Berlin Inst Hlth, Berlin, Germany
[14] Klin Schillerhohe, Robert Bosch Ctr Tumorerkrankungen, Stuttgart, Germany
[15] Klinikum Esslingen GmbH, Dept Pneumol, Esslingen, Germany
[16] Univ Med Oldenburg, Univ Dept Internal Med Oncol, Pius Hosp, Dept Hematol & Oncol, Oldenburg, Germany
[17] Univ Klin Innere Med Onkol, PIUS Hosp Oldenburg, Oldenburg, Germany
[18] Franziskus Hosp Harderberg, Dept Oncol, Niels Stensen Kliniken, Georgsmarienhutte, Germany
[19] SLK Fachklin Lowenstein, Lowenstein, Germany
[20] Sapienza Univ Rome, Dept Med Oncol, Policlin Umberto 1, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8085
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients
    Beltran-Bless, Ana-Alicia
    Shrem, Noa Shani
    Ghosh, Sunita
    Tajzler, Camilla
    Wood, Lori
    Kollmannsberger, Christian K.
    Basappa, Naveen S.
    Graham, Jeffrey
    Fallah-rad, Nazanin
    Heng, Daniel Yick Chin
    Soulieres, Denis
    Lalani, Aly-Khan A.
    Breau, Rodney H.
    Finelli, Antonio
    Tanguay, Simon
    Bhindi, Bimal
    Bjarnason, Georg A.
    Pouliot, Frederic
    Canil, Christina M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 367 - 367
  • [42] Treatment sequence after first-line nivolumab plus ipilimumab or sunitinib monotherapy in patients with metastatic renal cell carcinoma (mRCC) using real-world data.
    Geynisman, Daniel M.
    Faccone, Jillian
    Zhang Ying
    Ejzykowicz, Flavia
    Stwalley, Brian
    Hamilton, Melissa
    Le, Trong Kim
    Huo, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [43] Successful treatment of malignant pleural mesothelioma with nivolumab plus ipilimumab: A case report
    Park, Dong Won
    Chung, Sung Jun
    Lee, Hyun
    Kim, Sang-Heon
    Yoon, Ho Joo
    Sohn, Jang Won
    RESPIROLOGY, 2023, 28 : 287 - 287
  • [44] Ipilimumab and Nivolumab in the Treatment of Recurrent Malignant Pleural Mesothelioma: A Phase II Study
    Disselhorst, M.
    Harms, E.
    Van Tinteren, H.
    Quispel-Janssen, J.
    Monkhorst, K.
    Burgers, S.
    Baas, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1746 - S1746
  • [45] Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
    Cedres, Susana
    Assaf, Juan-David
    Iranzo, Patricia
    Callejo, Ana
    Pardo, Nuria
    Navarro, Alejandro
    Martinez-Marti, Alex
    Marmolejo, David
    Rezqallah, Alejandra
    Carbonell, Caterina
    Frigola, Joan
    Amat, Ramon
    Pedrola, Anna
    Dienstmann, Rodrigo
    Felip, Enriqueta
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Ipilimumab and nivolumab (I plus N) as first-line treatment of metastatic renal cell carcinoma (mRCC): A real-world review in North West of England, United Kingdom.
    Allison, Jennifer
    Griffiths, Richard
    Waddell, Tom
    Pillai, Manon Rhys
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [47] First-Line Nivolumab Plus Ipilimumab versus Chemotherapy in NSCLC
    不详
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 465 - 465
  • [48] Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
    Susana Cedres
    Juan-David Assaf
    Patricia Iranzo
    Ana Callejo
    Nuria Pardo
    Alejandro Navarro
    Alex Martinez-Marti
    David Marmolejo
    Alejandra Rezqallah
    Caterina Carbonell
    Joan Frigola
    Ramon Amat
    Anna Pedrola
    Rodrigo Dienstmann
    Enriqueta Felip
    Scientific Reports, 11
  • [49] Understanding real-world treatment patterns of patients with advanced ovarian cancer in the first-line maintenance setting: The FIRST STEP Study
    Cooney, Maureen
    Kalilani, Linda
    Kiss, Zsofia
    Golembesky, Amanda
    Kobayashi, Monica
    Dayma, Megha
    Coskuncay, Elif
    Schilder, Jeanne
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S202 - S203
  • [50] First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
    Baas, Paul
    Scherpereel, Arnaud
    Nowak, Anna K.
    Fujimoto, Nobukazu
    Peters, Solange
    Tsao, Anne S.
    Mansfield, Aaron S.
    Popat, Sanjay
    Jahan, Thierry
    Antonia, Scott
    Oulkhouir, Youssef
    Bautista, Yolanda
    Cornelissen, Robin
    Greillier, Laurent
    Grossi, Francesco
    Kowalski, Dariusz
    Rodriguez-Cid, Jeronimo
    Aanur, Praveen
    Oukessou, Abderrahim
    Baudelet, Christine
    Zalcman, Gerard
    LANCET, 2021, 397 (10272): : 375 - 386
12345